HAE
Haemonetics
PE ratio, current and historical analysis
- Stocks
- Healthcare
- NYSE: HAE
- PE Ratio
As of Jul 24, 2026, the HAE stock has a PE ratio of 38.24. The calculation is based on the latest EPS of $2.06 and the stock price of $78.78 per share. An increase of 81% has been observed in the PE ratio compared to its average of 21.2 of the last four quarters.
HAE PE ratio history
The mean historical PE ratio of Haemonetics over the last ten years is 96.66. The current 38.24 P/E ratio is 60% lower than the historical average. Looking back at the last ten years, HAE's PE ratio peaked in the Sep 2017 quarter at 641, with a price of $44.87 and an EPS of $0.07. The Sep 2025 quarter marked the lowest point at 14, with a price of $48.17 and an EPS of $3.44.
Haemonetics PE ratio by year
Maximum annual increase: 183.71% in 2015
Maximum annual decrease: -51.48% in 2023
| Year | PE ratio | PE change | Price | EPS |
|---|---|---|---|---|
| 2026 | 26.23 | 38.2% | $54.04 | $2.06 |
| 2025 | 18.98 | -48.41% | $63.19 | $3.33 |
| 2024 | 36.79 | 0.93% | $85.35 | $2.32 |
| 2023 | 36.45 | -51.48% | $82.75 | $2.27 |
| 2022 | 75.12 | 5.27% | $63.85 | $0.85 |
| 2021 | 71.36 | 6.75% | $112.04 | $1.57 |
| 2020 | 66.85 | -18.24% | $100.95 | $1.51 |
| 2019 | 81.76 | -3.89% | $87.48 | $1.07 |
| 2018 | 85.07 | N/A | $73.16 | $0.86 |
| 2017 | N/A | N/A | $40.57 | -$0.51 |
| 2016 | N/A | N/A | $35.29 | -$1.09 |
| 2015 | 133.97 | 183.71% | $44.21 | $0.33 |
| 2014 | 47.22 | -13.86% | $32.11 | $0.68 |
| 2013 | 54.82 | 107.73% | $41.66 | $0.76 |
| 2012 | 26.39 | 26.09% | $34.84 | $1.32 |
Haemonetics PE ratio by quarter (TTM)
| Year | PE ratio | PE change | Price | EPS |
|---|---|---|---|---|
| Mar 2026 | 26.23 | 19.28% | $54.04 | $2.06 |
| Dec 2025 | 21.99 | 57.07% | $80.28 | $3.65 |
| Sep 2025 | 14 | -37.58% | $48.17 | $3.44 |
| Jun 2025 | 22.43 | 18.18% | $73.8 | $3.29 |
| Mar 2025 | 18.98 | -37.36% | $63.19 | $3.33 |
| Dec 2024 | 30.3 | -7.73% | $77.57 | $2.56 |
| Sep 2024 | 32.84 | -10.3% | $79.8 | $2.43 |
| Jun 2024 | 36.61 | -0.49% | $82.73 | $2.26 |
| Mar 2024 | 36.79 | 7.57% | $85.35 | $2.32 |
| Dec 2023 | 34.2 | -3.42% | $85.51 | $2.5 |
| Sep 2023 | 35.41 | 11.88% | $89.58 | $2.53 |
| Jul 2023 | 31.65 | -13.17% | $85.14 | $2.69 |
| Apr 2023 | 36.45 | -12.88% | $82.75 | $2.27 |
| Dec 2022 | 41.84 | -5.06% | $78.65 | $1.88 |
| Oct 2022 | 44.07 | -13.59% | $74.03 | $1.68 |
HAE Price vs fair value
HAE average PE ratio chart
What this chart measures
The Historical Valuation Regime chart shows where the stock's current valuation sits relative to its own historical valuation range over the selected lookback period.
This is a history-relative tool, not a market-relative percentile. It does not compare the stock to other companies. Instead, it compares each historical valuation reading to the stock's own past readings.
Percentile logic
The threshold lines are calculated them from the stock's real historical values using percentile interpolation. That is why some colored bands are narrow while others are wide: the band widths reflect how the stock actually traded through time.
Regime map
| Historical percentile | Regime | Chart meaning |
|---|---|---|
| 0-10 | Historically Low | Deep cheap zone |
| >10-25 | Below Average | Cheap relative to history |
| >25-75 | Average | Within the normal historical range |
| >75-90 | Above Average | Expensive relative to history |
| >90-100 | Historically High | Extreme or stretched valuation |
How to read each part
| Chart element | What it tells you |
|---|---|
| Main line | The actual historical valuation values over time for the selected metric. |
| Dashed horizontal lines | The stock's computed P10, P25, Median, P75, and P90 thresholds for the selected period. |
| Colored bands | The historical valuation zones between those thresholds. |
| Metric boxes | Current ratio, historical median, current percentile, and current regime. |
| Timeline strip | A condensed regime history showing how the stock moved between cheap, fair, and expensive states across each observation. |
Important metric definitions
Current Percentile is the percentile rank of the latest valid historical observation within the selected lookback range.
Current Regime is assigned directly from the latest observation's percentile bucket using the fixed 10 / 25 / 75 / 90 cutoffs shown above.
How to use it well
This chart is most useful for answering a narrow question: Is this stock trading high, low, or normal relative to its own history? It works best alongside growth, profitability, and forward-looking business analysis, because a stock can deserve a higher or lower regime if its business quality has changed.
The current PE ratio of HAE is higher than its 3-year average, but it is lower than its 5 and 10-year averages.
PE comparison
Haemonetics's price to earnings (P/E) of 38.24 is higher than the Healthcare sector, the industry and its peers average. In comparison with the Healthcare sector average of 25.31, Haemonetics's price to earnings (P/E) is 51% higher.
HAE PE vs peers
In comparison to its peer BDX, HAE's PE ratio is lower, but it is higher than JNJ's and TMO's. Haemonetics's PE ratio is trading above the peer average of 32.18.
| Stock name | PE ratio | Market cap |
|---|---|---|
| MDT Medtronic plc | 22.19 | $106.51B |
| JNJ Johnson & Johnson | 30.17 | $634.77B |
| TMO Thermo Fisher Scientific Inc | 31.19 | $211.18B |
| SYK Stryker Corp | 37.79 | $126.6B |
| HAE Haemonetics Corp | 38.24 | $3.58B |
| BDX Becton Dickinson & Co | 39.58 | $43.08B |
| CERS Cerus Corp | N/A | $587.08M |
| BAX Baxter International Inc | N/A | $11.57B |
Frequently asked questions
What is Haemonetics's PE ratio?
As of Jul 24, 2026, HAE stock has a price to earnings ratio of 38.24.
What is the 3-year average PE ratio for Haemonetics (HAE)?
The 3-year average price to earnings ratio for HAE stock is 28.16.
What is the 5-year average PE ratio for Haemonetics (HAE)?
The 5-year average price to earnings ratio for HAE stock is 43.75.
What is the highest PE ratio for HAE?
Over the last ten years, the quarterly PE ratio reached its highest level at 641 in the Sep 2017 quarter.
How does the current PE ratio for HAE compare to its historical average?
HAE's current price to earnings ratio is 60% below its 10-year historical average.
How is HAE's PE ratio calculated (Haemonetics PE ratio formula)?
To determine the P/E ratio, divide the latest stock price by the TTM earnings per share (EPS). As of today (Jul 24, 2026), Haemonetics's share price is $78.78. The company's earnings per share for the trailing twelve months (TTM) ending Mar 2026 is $2.06. Therefore, Haemonetics's PE ratio for today is 38.24. PE RATIO(38.24) = STOCK PRICE($78.78) / TTM EPS($2.06)
All PE ratio stats are based on quarterly TTM periods, unless otherwise specified.